

Nature's Sunshine vs Medifast
Hersteller pflanzlicher Nahrungsergänzungsmittel mit Direktvertriebskanälen vs Verbrauchsgüterunternehmen. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.
Nature's Sunshine Products sells herbal supplements and wellness products through a direct-sales network of independent distributors, while Medifast markets structured weight-loss meal plans through its OPTAVIA coaching community. Both companies rely on peer-to-peer distribution models and face questions about distributor retention, regulatory scrutiny of health claims, and competition from mainstream retail. The Nature's Sunshine vs Medifast comparison explores how a diversified supplement seller's global distributor network stacks up against a weight-management company leaning into the GLP-1 era's shifting appetite for structured diet programs.
Nature's Sunshine Products sells herbal supplements and wellness products through a direct-sales network of independent distributors, while Medifast markets structured weight-loss meal plans through i...
Anlageanalyse
Vorteile
- Nature's Sunshine Products reported a revenue increase of 2.03% in 2024, demonstrating modest growth in sales.
- The company has a diversified portfolio spanning nutritional and personal care products sold globally.
- Recent quarterly results showed revenue growth of 12% year over year, surpassing market expectations and raising full-year guidance.
Zu beachten
- Earnings declined sharply by nearly 49% in 2024 despite revenue growth, indicating margin pressures or increased costs.
- The stock trades at a premium valuation relative to peers with modest top-line growth, suggesting possible overvaluation.
- Its stock price is 12% more volatile than the S&P 500, implying higher market risk and sensitivity.

Medifast
MED
Vorteile
- Medifast has a well-established position in the weight management and nutrition sector with strong brand recognition.
- The company benefits from multi-channel distribution including direct-sales, online, and retail partnerships.
- Medifast has demonstrated solid profitability and cash flow generation supporting reinvestment and shareholder returns.
Zu beachten
- Medifast faces significant competition from both established wellness brands and emerging niche players.
- The company is exposed to regulatory risks related to claims on weight-management products and dietary supplements.
- Its revenue and earnings are sensitive to consumer spending trends and macroeconomic fluctuations impacting discretionary health products.
NATR oder MED in Nemo kaufen
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.
6 % Zinsen auf Guthaben
Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.


